Patient Count Projections for Advanced Melanoma by Line of Therapy and Other Clinical Characteristics in EU Countries: Results from The UK, Germany, France, Italy and Spain (EU-5)
Gueron, B, Kish, J.K, O'Day, K, Martel, M.J, Manley Daumont, M
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
PGI12 The Impact of TNF Inhibitors for Crohn'S Disease on Health Care Resource Utilization: an Analysis Using the Ramq Database
Lachaine, J, Feagan, B, Martel, M.J, Beauchemin, C, Mchugh, K
Published in Value in health (01.06.2012)
Published in Value in health (01.06.2012)
Get full text
Journal Article
PCN396 CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-TS): ARE ONGOING CLINICAL TRIALS DESIGNED TO MEET EVIDENCE NEEDS OF KEY EUROPEAN HEALTH TECHNOLOGY ASSESSMENT BODIES (HTABS)?
Agashe, V., Watts-James, J., Arvin-Berod, C., Martel, M.J.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
PCN33 - Patient Count Projections for Advanced Melanoma by Line of Therapy and Other Clinical Characteristics in EU Countries: Results from The UK, Germany, France, Italy and Spain (EU-5)
Gueron, B., Kish, J.K., O'Day, K., Martel, M.J., Manley Daumont, M.
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article